IP Library Granted Patent US 8,840,919
Granted Patent B2
US 8,840,919 · App. 11/836,758 · Granted Sep 23, 2014

Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films

Inventor: Robert S. Davidson (Woodland Hills, CA)
Assignee: CURE Pharmaceutical Corporation
A61K9/0056A61K9/7007A61K9/0051
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,840,919
App. No.
11/836,758
Granted
Sep 23, 2014
Kind
B2
Abstract

A medicant composition is provided. The composition includes a film layer and a powder matrix layer. The powder matrix layer includes a medicant. The powder matrix layer is applied to the film layer by admixing particulate to form a powder matrix and by then applying the powder matrix to the film layer by any desired method. The composition of the powder matrix is varied to alter the dissolution rate of the medicant, the adhesion of the medicant composition, and other physical properties of the powder matrix. The powder matrix layer can be cured.

Claims (15)

1. A method of manufacturing a rapidly dissolving thin film for delivering a medicant in the oral cavity, comprising the steps of:

providing a film layer, wherein the film layer is rapidly dissolving; and

applying a coating to said film layer without use of a solvent, wherein said coating comprises a powder matrix;

wherein said coating, said film layer, or both, comprises a medicant;

the method further comprising a step of heating the film layer and powder matrix to a temperature above 76 degrees F, wherein the powder matrix comprises a lipid, wax or polyol and wherein the step of heating is at a temperature at about the softening point of the lipid, wax, or polyol, such that the lipid, wax, or polyol softens and flows to form a coating on the exterior of the film layer;

the powder matrix further comprising a composition that, when placed in the oral cavity in contact with the mucosa therein, adheres to the mucosa.

2. The method of claim 1 wherein the film layer dissolves within thirty seconds of being placed in an oral cavity.

3. The method of claim 1 wherein the film layer dissolves within fifteen seconds of being placed in the oral cavity.

4. The method of claim 1 wherein said medicant is selected from the group consisting of anti-inflammatory steroids, anti-inflammatory anodynes, anti-inflammatory enzymes, antihistamine agents, oral sterilizing agents, antibiotics, chemically therapeutic agents, cardiac strengthening agents, blood vein dilating agents, local narcotic agents, cough curing agents, sore throat and mouth treatment agents periodontal disease treatment agents, digesting organ curing agents, anti-diabetic agents, other enzymes, blood pressure depressing agents, tranquilizers, styptic agents, sexual hormones, and agents for curing virulent carcinoma or ulcers.

5. The method of claim 1 further comprising the step of preparing the coating in a fluidized bed.

6. The method of claim 1 wherein the coating is applied by sifting, screening, atomization, static or mechanical agitation.

7. The method of claim 6 wherein powder particles are charged.

8. The method of claim 6 wherein the coating is applied using a static spray gun.

9. The method of claim 8 wherein the static spray gun charges the powder particles such that the powder particles adhere to the surface of the film layer.

10. The method according to claim 1 wherein the powder matrix further comprises an adhesive, a bulking agent, or a sweetener, or any combination thereof.

Assignments (7)
LIEN Recorded Jan 28, 2025
From: CURE PHARMACEUTICAL, INC.
To: CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V.
Reel/Frame 070027/0201 →
CHANGE OF NAME Recorded Jul 17, 2023
From: TF TECH VENTURES, INC.
To: CURE PHARMACEUTICAL, INC.
Reel/Frame 064286/0450 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME WHICH SHOULD READ TF TECH VENTURES, INC. AND NOT TF TECH VENTURES PREVIOUSLY RECORDED AT REEL: 060598 FRAME: 0016. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 12, 2023
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES, INC.
Reel/Frame 064256/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2022
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES
Reel/Frame 060598/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2022
From: CURE PHARMACEUTICAL HOLDING CORP.
To: CURE PHARMACEUTICAL CORPORATION
Reel/Frame 060516/0576 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2020
From: CURE PHARMACEUTICAL CORPORATION
To: CURE PHARMACEUTICAL HOLDING CORP.
Reel/Frame 054445/0736 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: INNOZEN, INC.
To: CURE PHARMACEUTICAL CORPORATION
Reel/Frame 033065/0359 →
Continuity (2)
Division 10402273 · Mar 28, 2003
Related Publication 20070275040A1 · Nov 29, 2007